Princeton Bancorp chief lending officer sells shares for $31,372

Published 09/05/2025, 14:50
Princeton Bancorp chief lending officer sells shares for $31,372

PRINCETON, N.J.—Stephanie Adkins, Chief Lending Officer at Princeton Bancorp, Inc. (NASDAQ:BPRN), a regional bank with a market capitalization of $216 million, has sold 1,000 shares of the company’s common stock. The bank, currently trading near its InvestingPro Fair Value, offers investors a 3.8% dividend yield. The transaction, which took place on May 8, 2025, was executed at a price of $31.3724 per share, resulting in a total sale value of $31,372. Analysts maintain a moderate outlook on the stock, with price targets ranging from $32.50 to $35.00 per share.

Following this transaction, Adkins holds 10,794 shares of Princeton Bancorp stock. The sale was reported in a recent SEC filing and was signed by Edward Hogan as attorney-in-fact for Adkins. InvestingPro subscribers can access additional insights, including 5 more exclusive ProTips and comprehensive financial metrics for Princeton Bancorp.

In other recent news, Princeton Bancorp, Inc. announced the declaration of a quarterly cash dividend of $0.30 per share, with shareholders of record by May 6, 2025, set to receive payments on May 29, 2025. This move underscores the company’s commitment to delivering returns to its shareholders. Additionally, the company held its 2025 annual meeting, where shareholders elected eight directors and approved the executive compensation package. Wolf & Company, P.C. was ratified as the independent auditor for the fiscal year ending December 31, 2025.

Meanwhile, Privia Health Group, Inc. reported fourth-quarter earnings that exceeded analyst expectations, with an adjusted earnings per share of $0.21 against the estimated $0.05. The company achieved revenue of $460.9 million for the quarter, surpassing the projected $420.94 million. However, Privia Health’s 2025 revenue guidance of $1.8-1.9 billion fell short of analysts’ expectations of $1.89 billion, attributed to a challenging Medicare Advantage and value-based care environment. Despite this, the company forecasts growth in its implemented providers and an increase in adjusted EBITDA for 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.